| CRISPR Pioneer Zhang Preaches Extra Caution In Human Gene Editing | Alex Lash | 07/31/17 | Boston |
| With Helix’s Help, Lose It Adds Genetic Insights to Weight Loss App | Jeff Bauter Engel | 07/24/17 | Boston |
| New Study: DNA Tests For Healthy People Have “Uncertain Value” | Alex Lash | 06/28/17 | National |
| As Big Cancer Trials Ramp Up, Grail Goes Global, Merges With Cirina | Ben Fidler | 05/31/17 | San Francisco |
| Menlo Ventures Says Small Is Beautiful For New $450M Fund | Bernadette Tansey | 05/18/17 | San Francisco |
| Nipple Replacement Startup NovoThelium Sweeps Pitch Competitions | David Holley | 05/08/17 | Texas |
| Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M | Ben Fidler | 03/01/17 | San Francisco |
| PatientsLikeMe Nabs $100M, Works to Advance Personalized Medicine | Jeff Bauter Engel | 01/06/17 | Boston |
| Grail Raising $1 Billion To Fund Trials For Cancer DNA Test | Bruce V. Bigelow | 01/05/17 | San Diego |
| RaNA Expands, Joins Messenger RNA Drug Race With Shire Deal | Ben Fidler | 01/04/17 | Boston |
| Craig Venter Used Own Posh Health Clinic To Diagnose His Cancer | Alex Lash | 12/08/16 | San Francisco |
| CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ Haul | Alex Lash | 10/18/16 | Boston |
| With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 | Alex Lash | 07/12/16 | Boston |
| Seattle Week in Review: A Tragic Summer, Hoping “This Too Shall Pass” | Benjamin Romano | 07/08/16 | Seattle |
| Ginkgo Gulps $100M to Build Synthetic Food, Fragrance Business | Jeff Bauter Engel | 06/08/16 | Boston |
| Syros Files For IPO to Push “Gene Control” Drugs Through First Trials | Ben Fidler | 06/06/16 | Boston |
| With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist | Ben Fidler | 05/02/16 | Boston |
| How a San Antonio Company Joined In to Help Conjoined Twins In Need | David Holley | 04/15/16 | Texas |
| Tour of Texas: Cancer Moonshot, Lumos, Robyn Metcalfe, & Esperance | Angela Shah | 04/07/16 | Texas |
| Old Dog, New Tests: Embark Uses DNA Kit to Promote Canine Health | Angela Shah | 04/04/16 | Texas |
| Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer | Ben Fidler | 03/03/16 | Boston |
| Pronutria, Eyeing Clinical Push, Gets $42.5M From Nestle Health | David Holley | 02/23/16 | Boston |
| Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs | Ben Fidler | 01/26/16 | Boston |
| Same Twist, New Funding: Gene Synthesizer Raises $61M Series D | David Holley | 01/19/16 | San Francisco |
| With $100M, Guardant Health to Expand Reach of Blood Test for Cancer | David Holley | 01/07/16 | San Francisco |
| Synthetic Biology Primer: In Conversation With Richard Kitney, Part 1 | Alex Lash | 12/31/15 | National |
| In the Face of Genomic Data Challenges, the Cloud Keeps Us Afloat | Pieter van Rooyen | 12/29/15 | San Diego |
| With Drugs in Clinic, Constellation Nabs $55M For IPO Push | Alex Lash | 12/09/15 | Boston |
| Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M | Ben Fidler | 11/17/15 | Boston |
| Synthorx Makes Proteins Using Expanded Alphabet of Synthetic DNA | Bruce V. Bigelow | 08/20/15 | San Diego |
